{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:38:38Z","timestamp":1770892718074,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.hpb.2025.11.010","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:52:56Z","timestamp":1763693576000},"page":"218-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of neoadjuvant therapy on postoperative outcomes in patients undergoing hepatectomies for hepatocellular carcinoma"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5362-4827","authenticated-orcid":false,"given":"Sarah L.","family":"Yager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6980-5829","authenticated-orcid":false,"given":"Akin","family":"Erol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-5384","authenticated-orcid":false,"given":"Linda L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2025.11.010_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hpb.2025.11.010_bib2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.cgh.2021.07.048","article-title":"National trends and waitlist outcomes of locoregional therapy among liver transplant candidates with hepatocellular carcinoma in the United States","volume":"20","author":"Kwong","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2025.11.010_bib3","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1007\/s11605-021-05095-x","article-title":"Review of use of Y90 as a bridge to liver resection and transplantation in hepatocellular carcinoma","volume":"25","author":"Qadan","year":"2021","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2025.11.010_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072122","article-title":"Selecting the appropriate downstaging and bridging therapies for hepatocellular carcinoma: what is the role of transarterial radioembolization? A pooled analysis","volume":"15","author":"Lopez-Lopez","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.hpb.2025.11.010_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.5582\/bst.2023.01322","article-title":"Conversion therapy for initially unresectable hepatocellular carcinoma: current status and prospects","volume":"17","author":"Ma","year":"2024","journal-title":"Biosci Trends"},{"key":"10.1016\/j.hpb.2025.11.010_bib6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/SLA.0000000000006061","article-title":"Resection postradioembolization in patients with single large hepatocellular carcinoma","volume":"278","author":"Tzedakis","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.11.010_bib7","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2025.11.010_bib8","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jvir.2018.06.027","article-title":"Outcomes of surgical resection after radioembolization for hepatocellular carcinoma","volume":"29","author":"Gabr","year":"2018","journal-title":"J Vasc Intervent Radiol"},{"key":"10.1016\/j.hpb.2025.11.010_bib9","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.cgh.2022.02.018","article-title":"UNOS down-staging criteria for liver transplantation of hepatocellular carcinoma: systematic review and meta-analysis of 25 studies","volume":"21","author":"Tan","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2025.11.010_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.soi.2025.100146","article-title":"Efficacy of Yttrium90 transarterial radioembolization as a bridge to surgery in hepatocellular carcinoma","volume":"2","author":"Wong","year":"2025","journal-title":"Surgical Oncology Insight"},{"key":"10.1016\/j.hpb.2025.11.010_bib11","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/JS9.0000000000000256","article-title":"TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study","volume":"109","author":"Yuan","year":"2023","journal-title":"Int J Surg"},{"key":"10.1016\/j.hpb.2025.11.010_bib12","article-title":"Combination therapy of chemoembolization and hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis compared with chemoembolization alone: a propensity score-matched analysis","author":"Liu","year":"2021","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.hpb.2025.11.010_bib13","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1097\/JS9.0000000000001819","article-title":"Lenvatinib plus drug-eluting bead transarterial chemoembolization with\/without hepatic arterial infusion chemotherapy for hepatocellular carcinoma larger than 7 Cm with major portal vein tumor thrombosis: a multicenter retrospective cohort study","volume":"110","author":"Cai","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.hpb.2025.11.010_bib14","unstructured":"Variables & definitions chapter 4: hepatectomy. ACS NSQIP operations manual. American College of Surgeons. Last Updated January 1, 2022."},{"key":"10.1016\/j.hpb.2025.11.010_bib15","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2025.11.010_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/jso.27738","article-title":"A review of portal vein embolization prior to hepatic resection","volume":"130","author":"Sivakumar","year":"2024","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hpb.2025.11.010_bib17","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1245\/s10434-017-5800-z","article-title":"Efficacy of preoperative portal vein embolization among patients with hepatocellular carcinoma, biliary tract cancer, and colorectal liver metastases: a comparative study based on single-center experience of 319 cases","volume":"24","author":"Yamashita","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.11.010_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/SLA.0b013e31815f6e5b","article-title":"Preoperative portal vein embolization for major liver resection: a meta-analysis","volume":"247","author":"Abulkhir","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.11.010_bib19","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s13304-023-01571-y","article-title":"Sequential transcatheter arterial chemoembolization and portal vein embolization before hepatectomy for the management of patients with hepatocellular carcinoma: a systematic review and meta-analysis","volume":"75","author":"Liao","year":"2023","journal-title":"Updates Surg"},{"key":"10.1016\/j.hpb.2025.11.010_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000315239","article-title":"Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010","volume":"78","author":"Kudo","year":"2010","journal-title":"Oncology"},{"key":"10.1016\/j.hpb.2025.11.010_bib21","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/104685","article-title":"Radiofrequency ablation of hepatocellular carcinoma: a literature review","author":"Minami","year":"2011","journal-title":"International Journal of Hepatology"},{"key":"10.1016\/j.hpb.2025.11.010_bib22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9610(99)00068-9","article-title":"Radiofrequency ablation followed by resection of malignant liver tumors","volume":"177","author":"Scudamore","year":"1999","journal-title":"Am J Surg"},{"key":"10.1016\/j.hpb.2025.11.010_bib23","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4254\/wjh.v6.i12.844","article-title":"Transarterial chemoembolization for hepatocellular carcinoma: a review of techniques","volume":"6","author":"Imai","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hpb.2025.11.010_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/SLA.0b013e3181961c16","article-title":"A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma","volume":"249","author":"Zhou","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.11.010_bib25","volume":"14","author":"Luo","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.hpb.2025.11.010_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1165538","article-title":"Case report: a case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilobar lesion combining with systemic therapies and sequential hepatectomy","volume":"13","author":"Wei","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.hpb.2025.11.010_bib27","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"IMbrave150 investigators. Atezolizumab plus Bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hpb.2025.11.010_bib28","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.hpb.2025.11.010_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s13304-025-02310-1","article-title":"Liver resection following neoadjuvant immunotherapy: a single center retrospective study","author":"Podrascanin","year":"2025","journal-title":"Updates Surg"},{"key":"10.1016\/j.hpb.2025.11.010_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000042973","article-title":"Surgical resection of vascular-invasive late-stage hepatocellular carcinoma following transarterial chemoembolization combined with lenvatinib and tislelizumab: two case reports and literature review","volume":"104","author":"Qian","year":"2025","journal-title":"Medicine (Baltim)"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25017101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25017101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:48:43Z","timestamp":1770889723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X25017101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1365182X25017101"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2025.11.010","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of neoadjuvant therapy on postoperative outcomes in patients undergoing hepatectomies for hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2025.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}